Manjak alfa-1 antitripsina (AATD)

Manjak alfa-1 antitripsina (AATD) nasljedna je bolest koja uzrokuje povećani rizik od kronične opstruktivne plućne bolesti (KOPB), bolesti jetre, kožnih problema (panikulitis) i upale krvnih žila (vaskulitis).

Manjak alfa-1 antitripsina (AATD)Download
The Croatian Alliance for Rare Diseases is a recipient of institutional support from the National Foundation for Civil Society Development for the stabilization and/or development of the association.
The content of the website is the sole responsibility of the Croatian Alliance for Rare Diseases
The creation of the website was co-financed by the European Union from the European Social Fund
European Union

Together for EU Funds

Learn more about the project

About us

Management Board

Member Associations

External Collaborators

Copyright 2020 Hrvatski savez za rijetke bolesti.
Development by Fugaj Creative.
en_GBEN
hrHR en_GBEN